As the Founder and COO of Korio, Inc., Chuck Harris is at the forefront of transforming clinical trials through innovative technology solutions. With a robust background in executive management and a deep understanding of the pharmaceutical industry, Chuck leads Korio’s mission to empower stakeholders in...
As the Founder and COO of Korio, Inc., Chuck Harris is at the forefront of transforming clinical trials through innovative technology solutions. With a robust background in executive management and a deep understanding of the pharmaceutical industry, Chuck leads Korio’s mission to empower stakeholders in clinical research to achieve more with cutting-edge clinical technology. His expertise spans a wide array of specialties, including e-Clinical solutions, clinical trial management, and regulatory affairs, positioning him as a thought leader in the field.
Under Chuck's leadership, Korio has embarked on key projects that leverage the insights of top subject matter experts to streamline trial setup and management. By integrating advanced features such as Interactive Voice Response (IVR) and Interactive Response Technology (IRT) into their platform, Korio disrupts traditional methodologies, enabling faster and more efficient trial processes. Chuck’s commitment to quality assurance and compliance ensures that all solutions meet the stringent requirements of U.S. Title 21 CFR Part 11 regulations, thereby enhancing the integrity of clinical data.
His strategic vision also encompasses product and platform development, where he focuses on creating user-friendly interfaces that facilitate seamless project management and validation processes. By fostering a culture of innovation and collaboration, Chuck Harris is not only driving Korio’s growth but also shaping the future of clinical trials, making them more accessible and effective for researchers and participants alike.
